SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-19-000828
Filing Date
2019-03-01
Accepted
2019-03-01 13:57:58
Documents
91
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2237838z10-k.htm 10-K 1669177
2 EX-21 a2237838zex-21.htm EX-21 4321
3 EX-23.1 a2237838zex-23_1.htm EX-23.1 3696
4 EX-31.1 a2237838zex-31_1.htm EX-31.1 7449
5 EX-31.2 a2237838zex-31_2.htm EX-31.2 7463
6 EX-32.1 a2237838zex-32_1.htm EX-32.1 4577
7 EX-32.2 a2237838zex-32_2.htm EX-32.2 4597
14 G875435.JPG g875435.jpg GRAPHIC 58657
15 G927356.JPG g927356.jpg GRAPHIC 42833
  Complete submission text file 0001047469-19-000828.txt   9852015

Data Files

Seq Description Document Type Size
8 EX-101.INS supn-20181231.xml EX-101.INS 2519940
9 EX-101.SCH supn-20181231.xsd EX-101.SCH 69307
10 EX-101.CAL supn-20181231_cal.xml EX-101.CAL 90030
11 EX-101.DEF supn-20181231_def.xml EX-101.DEF 279809
12 EX-101.LAB supn-20181231_lab.xml EX-101.LAB 686551
13 EX-101.PRE supn-20181231_pre.xml EX-101.PRE 463952
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-35518 | Film No.: 19648246
SIC: 2834 Pharmaceutical Preparations